Effects of Exercise on Acute Concussion Symptoms and Recovery in Adults
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04539509 |
|
Recruitment Status :
Suspended
(Revising study protocol.)
First Posted : September 7, 2020
Last Update Posted : October 6, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Concussion, Mild Mild Traumatic Brain Injury | Behavioral: Exercise Prescription Behavioral: Treadmill Test Device: Monitoring | Not Applicable |
435 people will participate in this study.
A physician will review a participant's medical history to determine if physical activity is appropriate for them. They will then be randomly assigned to 1 of 3 study groups:
- Monitoring- participants will be given a heart rate monitor to wear on their wrist for the duration of the study (until "recovered", or until 8 weeks post-concussion, whatever comes first).
- Monitoring + Treadmill Testing- in addition to wearing the heart rate monitor, they will undergo a treadmill test at each appointment.
- Monitoring + Treadmill Testing + Specific Exercise Prescription- in addition to wearing the heart rate monitor, and treadmill test, they will receive an exercise prescription based on the results of the treadmill test.
The randomization is by chance. Participants have a 40/20/40% respective chance of being assigned to the study groups above. This means that out of every 5 people: 2 people will be assigned to the group 1, 1 will be assigned to the group 2, and 2 will be assigned to the group 3. Both participants and the study doctor will be aware which group participants are in.
Regardless of the group assigned, participants will receive an exercise prescription form at each appointment, as per usual care. The prescription will be based on the physician's judgement. If a participant is in group 3, their prescription will also take into account the results of the treadmill test.
Recovery will be determined using a 3-step approach:
- Self-reported symptoms,
- Clinic physician's opinion,
- Treadmill test results (if applicable).
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 435 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Masking Description: | The primary outcome (recovery) is determined using a 3 step approach. Each assessor responsible for one of the three steps, will be blind to at least ONE other recovery determinant. |
| Primary Purpose: | Treatment |
| Official Title: | The Development of a Rapid Access Concussion Care and Research Clinic - Effects of Exercise on Acute Concussed Adults Referred to a Rapid Access Concussion Clinic |
| Actual Study Start Date : | January 1, 2021 |
| Estimated Primary Completion Date : | August 2024 |
| Estimated Study Completion Date : | December 2024 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Monitoring
Participants will be given a heart rate monitor to wear on their wrist for the duration of the study (i.e. until recovered, or 8 weeks post-injury, whatever comes first).
|
Device: Monitoring
Activity monitoring using a Fitbit. |
|
Placebo Comparator: Monitoring + Treadmill Test
In addition to wearing the heart rate monitor, participants will undergo a treadmill test at each appointment.
|
Behavioral: Treadmill Test
A symptom-limited treadmill test, using the Buffalo Concussion Treadmill Test (BCTT) protocol. Device: Monitoring Activity monitoring using a Fitbit. |
|
Experimental: Monitoring + Treadmill Test + Specific Exercise Prescription
In addition to wearing the heart rate monitor, and completing a treadmill test at each appointment, participants will receive an exercise prescription based on the results of the treadmill test. They will be prescribed 30 minutes of structured aerobic exercise, 5 times per week, at a heart rate determined by their treadmill test.
|
Behavioral: Exercise Prescription
A specific exercise prescription, based on the results of a treadmill test. Behavioral: Treadmill Test A symptom-limited treadmill test, using the Buffalo Concussion Treadmill Test (BCTT) protocol. Device: Monitoring Activity monitoring using a Fitbit. |
- Percentage of Participants Recovered [ Time Frame: Assessed at week 8 post-concussion. ]
"Recovery" (yes/no) will be determined using a 3-step approach:
- Self-reported symptoms (using the Sport Concussion Assessment Tool [SCAT], Symptom Inventory),
- Clinic physician's opinion,
- Treadmill test results (if applicable).
- Percentage of Participants Recovered [ Time Frame: Assessed at week 2 post-concussion. ]
- Percentage of Participants Recovered [ Time Frame: Assessed at week 4 post-concussion. ]
- Percentage of Participants who have Returned to Work/School [ Time Frame: Assessed at week 2 post-concussion. ]Time at which participants return to part-time and/or full-time work or school activities.
- Percentage of Participants who have Returned to Work/School [ Time Frame: Assessed at week 4 post-concussion. ]
- Percentage of Participants who have Returned to Work/School [ Time Frame: Assessed at week 8 post-concussion. ]
- Brief Symptom Inventory-18 (BSI-18) Global Severity Index Score [ Time Frame: Assessed at week 2 post-concussion. ]
Measured using the Brief Symptom Inventory (BSI)-18. Global scores, as well as somatization, depression, and anxiety sub-scales will be included.
Global scores are calculated by adding up participants self-reported score (0-72), with high scores indicating more psychological distress. These scores are then compared to gender-stratified norms. Sub-scales are scored on a 0-24 scale, again higher scores indicating more psychological distress (sub-scales also compared to gender-stratified norms).
- Brief Symptom Inventory-18 (BSI-18) Global Severity Index Score [ Time Frame: Assessed at week 4 post-concussion. ]
- Brief Symptom Inventory-18 (BSI-18) Global Severity Index Score [ Time Frame: Assessed at week 8 post-concussion. ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 17 Years to 55 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients that provide written informed consent prior to entry into the study
- Patients referred from the emergency department (ED) with recent (<1 week) diagnosis of concussion by ED physician
- GCS score of 13-15 on presentation to the ED
- SCAT score > 9 at week 1
- Physician cleared for exercise; low risk for cardiac disease (defined as no cardiopulmonary symptoms and meet no more than one risk factor for heart disease)
- Willing to exercise
Exclusion Criteria:
- Evidence of intracranial hemorrhage, contusion or injury on brain imaging (CT Scan)
- Beta-blocker medication
- High dose (>50mg/day) tricyclic antidepressant medication
- Pre-existing or current orthopedic injuries preventing exercise
- Pre-existing vestibular disease preventing exercise
- Heartrate increase <30 bpm from rest on treadmill test
- Deemed asymptomatic from concussion by clinic physician
- Unable/unwilling to follow commands
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04539509
| Canada, Ontario | |
| Toronto Rehabilitation Institute - University Health Network | |
| Toronto, Ontario, Canada, M5G 2A2 | |
| Principal Investigator: | Mark Bayley, MD | University Health Network, Toronto Rehabilitation Institute |
| Responsible Party: | University Health Network, Toronto |
| ClinicalTrials.gov Identifier: | NCT04539509 |
| Other Study ID Numbers: |
CAPCR ID: 15-9214 |
| First Posted: | September 7, 2020 Key Record Dates |
| Last Update Posted: | October 6, 2021 |
| Last Verified: | September 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Plan Description: | No IDP sharing plan. |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Concussion Mild traumatic brain injury Aerobic exercise |
|
Brain Injuries Brain Injuries, Traumatic Brain Concussion Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Craniocerebral Trauma Trauma, Nervous System Wounds and Injuries Head Injuries, Closed Wounds, Nonpenetrating |

